申请人:Glaxo Group Limited
公开号:US04808581A1
公开(公告)日:1989-02-28
The invention relates to compounds of formula (I): ##STR1## and physiologically acceptable salts or solvates thereof, wherein Im represents an imidazolyl group of formula: ##STR2## and the various substituents are defined hereinbelow. The compounds are potent and selective antagonists of the effect of 5-HT at 5-HT.sub.3 receptors and are useful, for example, in the treatment of psychotic disorders, anxiety, and nausea and vomiting.
该发明涉及公式(I)的化合物:##STR1##及其生理上可接受的盐或溶剂化合物,其中Im代表公式的咪唑基团:##STR2##各种取代基在此定义。这些化合物是5-HT.sub.3受体上5-HT效应的有效和选择性拮抗剂,例如在治疗精神病性障碍、焦虑和恶心呕吐方面有用。